Tag: CORO
U.S. COVID-19 Hospitalizations Rise for Fourth Straight Week
The variant EG.5 is now the dominant variant in the country, comprising 17.3 percent of U.S. infections
Long COVID Symptoms Persist Through 12 Months
Two studies show symptoms emerge, reemerge through 12 months; activity limitation persists among those with long COVID
Moderna COVID-19 Vaccine Tied to Lower Adverse Event Risk in Older Adults
mRNA-1273 vaccine also tied to greater protection against COVID-19 in older adults
New COVID-19 Variant EG.5 Now Dominant in U.S., CDC Says
EG.5 is one of several closely related omicron subvariants that have been competing for dominance in recent months
Oral Probenecid Cuts Time to Viral Clearance in COVID-19
Median time to viral clearance was significantly shorter for 500, 1,000 mg probenecid versus placebo
Biden Administration Launches Office for Long COVID Research
The Office of Long COVID Research and Practice will lead the U.S. response to long COVID, which includes trials that have already been launched
Amygdala and Insula Retraining Tied to Reduction in Fatigue With Long COVID
Furthermore, patients randomly assigned to the neuroplasticity program saw significant gains in energy
Long COVID Seen in 16.2 Percent of Pediatric COVID-19 Patients
Review also shows developing certain long COVID symptoms may be associated with female gender
Deaths Due to Opioid Toxicity Up in U.S. During COVID-19
Years of life lost due to opioid toxicity plateaued between 2017 and 2019, then increased through 2021
CDC: More Than Three-Quarters of Americans 16 and Older Have Been Infected With COVID-19
Federal figures have made it clear how much the virus spread undetected or unreported
